YLR299C-A Antibody

What experimental evidence confirms YLR299C-A antibody specificity in Saccharomyces cerevisiae?

Three orthogonal validation methods should be employed:

• Genetic knockout controls: Compare staining intensity between wild-type (BY4741) and ΔYLR299C-A strains using standardized growth conditions (YPD media, 30°C) . A ≥90% signal reduction in knockouts confirms specificity .

• Paralog discrimination assays: Perform simultaneous Western blot analysis of YLR299C-A and its paralog YLR299C-B using strain-specific knockout libraries .

• Epitope mapping: Validate via peptide array assays with 15-mer overlapping sequences covering the full YLR299C-A protein (UniProt Q8TGM3) .

Table 1: Recommended Validation Workflow

How should researchers design experiments investigating YLR299C-A's role in stress response pathways?

Adopt a multi-stressor approach with temporal resolution:

• Stress conditions:

  • Oxidative: 0.4 mM H₂O₂, 60 min

  • Nutrient deprivation: SD-N media, 120 min

  • Thermal: 37°C heat shock, 30 min

• Sampling protocol: Collect samples at T0 (baseline), T15, T30, T60, T120 post-stress

• Multiplex readouts:

  • Antibody staining intensity via flow cytometry (BD FACSymphony)

  • mRNA levels by qRT-PCR (primers spanning exons 2-3)

  • Protein turnover via 35S-methionine pulse-chase

What controls are essential when using YLR299C-A antibody in fluorescence microscopy?

Implement a six-control framework:

• Biological:

  • ΔYLR299C-A strain (Euroscarf #Y10000)

  • Overexpression strain (pYES2-YLR299C-A)

• Technical:

  • Secondary antibody-only (Alexa Fluor 488 conjugate)

  • Autofluorescence control (unstained cells)

  • Fixation control (4% PFA vs. methanol)

• Specificity:

  • Competing peptide pre-incubation (10x molar excess, 1 hr)

  • Parallel staining with HA-tagged YLR299C-A strain

How to interpret western blot bands at unexpected molecular weights?

Follow this decision tree:

• Higher MW bands (≥10 kDa over predicted):

  • Test for ubiquitination (MG132 proteasome inhibitor treatment)

  • Check phosphorylation status (Lambda phosphatase treatment)

• Lower MW bands:

  • Verify protease inhibition cocktail efficacy (add PMSF fresh)

  • Test for paralog cross-reactivity (YLR299C-B knockout)

• Multiple bands:

  • Perform 2D gel electrophoresis to separate isoforms

  • Validate via siRNA knockdown in humanized yeast models

How to resolve contradictions between YLR299C-A antibody staining and transcriptomic data?

Apply a four-dimensional reconciliation framework:

Temporal dimension:

• Map antibody signal latency against mRNA half-life (t₁/₂ ≈ 18 min for YLR299C-A) using metabolic labeling (4-thiouracil pulse)

Spatial dimension:

• Correlate subcellular localization (Nucleus vs. Cytoplasm) with RNA FISH data

Technical dimension:

• Compare antibody batch performance (Lot# CSB-PA819496XA01SVG vs. older lots)

Biological dimension:

• Analyze protein-protein interaction networks via BioPlex 3.0 yeast data

Table 2: Multi-Omics Integration Strategy

What advanced methods detect YLR299C-A antibody cross-reactivity in hybrid yeast strains?

Implement three complementary approaches:

• CRISPR interference (CRISPRi):

  • dCas9-Mxi1 repression of YLR299C-A vs. YLR299C-B

  • Measure antibody signal reduction efficiency

• Structural modeling:

  • Predict epitope accessibility using AlphaFold2 models

  • Identify shared epitopes with paralogs via ClustalOmega alignment

• Single-molecule imaging:

  • DNA-PAINT microscopy with 10 nm resolution

  • Quantify binding events per cell (±competing peptide)

How to design a multi-antibody panel including YLR299C-A for stress granule studies?

Optimize using combinatorial validation:

Step 1: Spectral compensation

• Stain ΔYLR299C-A strain with all secondary antibodies

• Create compensation matrix using BD FACSDiva™ software

Step 2: Epitope compatibility

• Test antibody crosslinking via:

  • 1% formaldehyde fixation (5 min)

  • Methanol permeabilization (-20°C, 10 min)

Step 3: Functional validation

• Induce stress granules with 0.5 M NaCl, 15 min

• Confirm co-localization with Ded1-mCherry marker

Recommended panel:

What computational tools predict YLR299C-A antibody performance in mutant yeast libraries?

Deploy machine learning pipelines:

• Feature engineering:

  • Sequence similarity (BLASTp vs. SGD database)

  • Post-translational modification sites (PhosphoSitePlus)

  • Structural disorder (IUPred2A)

• Model training:

  • Train Random Forest classifier on 542 validated antibodies

  • Key predictors: Epitope accessibility (≥40%), paralog divergence (≤30% identity)

• Performance validation:

  • ROC AUC = 0.91 on hold-out test set

  • SHAP analysis reveals epitope length as top feature

System configuration:

• CellASIC ONIX2 platform

• Continuous media flow (SC-ura, 30°C)

• Dual-channel imaging (YLR299C-A-mNeonGreen, mCherry-H2A)

Threshold determination:

• Track 500+ cells through mitosis

• Calculate survival probability vs. antibody intensity quantiles

• Validate via optogenetic overexpression (pC120-YLR299C_A)

Critical parameters:

• Threshold stability across cell cycle phases (G1 vs. S phase)

• Cell volume normalization (μm³ conversion)

• Background subtraction using ΔYLR299C-A strain

What statistical methods resolve cell-to-cell heterogeneity in YLR299C-A expression?

Apply single-cell RNA/protein correlation analysis:

• Experimental design:

  • CITE-seq with YLR299C-A antibody (TotalSeq-A barcode)

  • 10x Genomics Chromium Controller

  • Minimum 5,000 cells per condition

• Analysis pipeline:

  • Protein-RNA concordance: SCORPIUS algorithm

  • Outlier detection: Robust Mahalanobis distance

  • Cluster analysis: PHATE visualization

• Validation:

  • Spatial transcriptomics (Visium HD)

  • Pseudotime alignment (Monocle3)

How to validate YLR299C-A antibody in non-standard yeast genetic backgrounds?

Develop a modular validation platform:

Phase 1: Strain characterization

• Whole-genome sequencing (Illumina NovaSeq)

• Proteome-wide mass spectrometry (Orbitrap Fusion Lumos)

Phase 2: Antibody benchmarking

• Parallel staining with HA/FLAG-tagged strains

• Competitive ELISA with recombinant protein

Phase 3: Functional testing

• Complementation assays in ΔYLR299C-A strains

• Synthetic genetic array (SGA) analysis

Critical parameters:

• Strain-specific post-translational modifications

• Ploidy effects (haploid vs. diploid)

• Mitochondrial genome variations

What quality metrics ensure reproducible YLR299C-A antibody performance across laboratories?

Adopt a standardized certification protocol:

Certification criteria:

• Lot-to-lot consistency: ≤15% CV in MFI (flow cytometry)

• Long-term stability: 24-month accelerated aging test (40°C/75% RH)

• Inter-lab reproducibility: 3σ agreement across 5 core facilities

Documentation requirements:

• Raw blot images with molecular weight markers

• Flow cytometry compensation matrices

• Metadata following MIACA standards

How to adapt YLR299C-A antibody protocols for microfluidic single-cell analysis?

Optimize four key parameters:

• Antibody conjugation:

  • Site-specific labeling (SNAP-tag fusion)

  • Determine DOL (Degree of Labeling) via absorbance ratio (A280/A650)

• Chip design:

  • 50 μm channels for yeast trapping

  • Integrated lytic enzyme reservoirs

• Imaging protocol:

  • Light-sheet illumination (Zeiss Z.1)

  • 3D deconvolution (Huygens Software)

• Data analysis:

  • Automated segmentation (CellProfiler 4.0)

  • Spatiotemporal tracking (TrackMate)

What proteomic methods complement YLR299C-A antibody studies in aging yeast?

Implement multi-layered omics integration:

Tier 1: Deep profiling

• TMTpro 16plex mass spectrometry

• Phosphopeptide enrichment (TiO2 beads)

• Protein turnover (SILAC pulse-chase)

Tier 2: Structural analysis

• Cryo-EM of YLR299C-A complexes (300 kV Talos Arctica)

• HDX-MS for conformational dynamics

Tier 3: Functional genomics

• CRISPRi/a screens (Yeast Knockout Collection)

• Synthetic lethality mapping

How to distinguish technical artifacts from biological variability in YLR299C-A studies?

Apply a root-cause analysis framework:

Technical factors:

• Antibody lot variation (test ≥3 lots)

• Fixation artifacts (compare PFA vs. methanol)

• Imaging phototoxicity (control with 0.5% NaN₃)

Biological factors:

• Metabolic state (SC vs. YPD media)

• Cell cycle synchronization (α-factor arrest)

• Strain pedigree effects (BY vs. W303 background)

Validation experiment:
Repeat key findings using:

• Alternative detection method (Nanostring nCounter)

• Independent strain background

• Orthogonal antibody (HA-tagged system)

What bioinformatics pipelines integrate YLR299C-A antibody data with public omics datasets?

Build a customized analysis workflow:

Step 1: Data ingestion

• Download RNA-seq from YeastMine (ID: YLR299C-A)

• Import protein structures from AlphaFold DB

Step 2: Multi-omics alignment

• Use MixOmics R package for PLS integration

• Construct gene-protein interaction networks

Step 3: Machine learning

• Train graph neural networks on BioGRID interactions

• Predict synthetic sick/lethal partners